Two salesman, a start-up company and the greatest medical invention of all time

Two salesman, a start-up company and the greatest medical invention of all time

The hypodermic injection (comprising syringe and needle together with the substance that it delivers) is thought to be a piece of medical technology responsible for saving more lives and alleviating more suffering than any other.

Proving its worth by the billions, the hypodermic injection is critical in the fight to end the current world-wide pandemic by delivering vaccines for Covid-19 to millions of people across the globe every day. The World Health Organization says that “vaccines are a critical new tool in the battle against Covid-19” and that “safe and effective vaccines will be a gamechanger.”

The history of the humble injection is an interesting one dating back to the 17th century. The earliest confirmed experiments of intravenous injections were in 1656 and since then, fundamentally, not much has changed. Sir Christopher Wren is perhaps best known for his architecture, which includes his masterpiece St Paul’s Cathedral, and not for the fact that it was him that first experimented to see if drugs administered intravenously had the same effect as when given orally. He did this by injecting wine and ale into a dog’s veins using an animal bladder as a syringe and goose quill as a needle.

In 1844 Wren’s design was refined when Irish physician Francis Rynd injected painkillers using a hollow mental needle. Margaret Cox presented with dental and facial pain that Rynd treated by “injecting fifteen grains of acetate of morphia, dissolved in one drachm of creosote… [into the nerves] … by four punctures of an instrument made for the purpose.” This account is widely considered to be of the first hypodermic injections.

Shortly after, in 1853 French surgeon Charles Pravaz developed the first metal syringe and added the hollow needle to the end rather than the tube, refining Rynd’s idea further. Scottish physician Alexander Wood used this device to inject morphine into a patient and published details of the innovation in a paper called “A New Method for Treating Neuralgia by the Direct Application of Opiates to Painful Points” in the Edinburgh Medical and Surgical Journal (1855).

The word “hypodermic” is credited to London surgeon Charles Hunter who in 1858 combined the Greek words hypo “under” and derma “skin” to describe subcutaneous injection.

Later, in 1897 Maxwell Becton and Fairleigh Dickinson, two salesmen that met on a business trip, founded Becton, Dickinson and Company (also known as BD). A medical technology company that in 1898 paid $40 for half interest in patent rights to an all-glass syringe. In 1906 they started the first manufacturing facility in the United States and in 1924 manufactured the first syringe designed specifically to deliver insulin.

Between 1949 and 1950 Arthur E. Smith was awarded eight US patents for the first disposable syringe but it was BD who mass-produced the devices for Dr Jonas Salks mass polio vaccination programme. This design was refined further by Colin Murdoch in 1956 and the design is still in use today. Once again, however, it was Becton and Dickinson’s start-up company that brought the product to the mass market.

The history of the now commonplace device is a rich tapestry of scientific minds, a desire to explore the unknown and relieve human suffering, an architect, and a drunken dog. But it was two salesman and a start-up company that made the greatest medical invention of all time accessible to the masses and paved the way for vaccination programmes, like the one we see in the fight against Covid-19 today, to be rolled out in large scales. Partner & Patent Attorney Dr Elliott Davies said “it’s human nature to want to improve and develop, and the story of the hypodermic syringe is a classic example of this human endeavour. Developments in medicine and medical devices are always well received, not least by those who need them most, and particularly in these “COVID” times where we all look for urgent answers to previously unknown problems.”

Wynne-Jones IP are proud to offer a specialist patent service designed specifically for entrepreneurs, start-ups and SMEs to provide the protection you need at affordable prices. For more information please call us on +44 01242 267600. 

Related News

Wynne-Jones IP supports Mental Health Awareness Week
news

Wynne-Jones IP supports Mental Health Awareness Week

Wynne- Jones IP are proud to support Mental Health Awareness Week which takes place from Monday 10th May to Sunday 16th May 2021.

The Coronavirus pandemic has created new global challenges with many people suffering from increased stress and anxiety. Wynne-Jones IP are making a real effort to ensure staff feel supported and making both physical and mental wellness a priority.

Inventions that changed the world – SME edition
news

Inventions that changed the world – SME edition

Entrepreneurs and small businesses play a critical role in the economy and this year World Intellectual Property Day focus’ on how they can use intellectual property (IP) rights to build “stronger, more competitive and resilient businesses.”

Some of the world’s best-known inventions and brands are the products of inventors and entrepreneurs who were savvy enough to protect their ideas. This week, to mark World IP Day we’ll be looking at five of our favourites, beginning with Thomas Edison.

When brand development can be a warzone it's vital that every General has a battle plan
news

When brand development can be a warzone it's vital that every General has a battle plan

Every day, businesses across the globe invest significant sums of money in building brands and launching products that have shaky foundations. Often, entrepreneurs and business owners are unaware of the risks until they find shots are being fired at them. Large companies are often willing to take on the fight since they have the necessary resources, but for some small businesses with less resources it can be a fight for their life…

How do you send a caterpillar 100 feet in the air?
news

How do you send a caterpillar 100 feet in the air?

The case of Colin the Caterpillar -v- Cuthbert the Caterpillar has caught the media’s attention.  In case you have been cocooned away and missed it, on 15th April 2021, Marks and Spencer (M&S) launched high court proceedings in the UK against discount supermarket, Aldi, alleging trade mark infringement and passing off. 

The thing everyone wants to know now is whether the case has legs.

How a Mexican yam and a start-up company transformed the lives of women
news

How a Mexican yam and a start-up company transformed the lives of women

Russell Marker, Carl Djerassi and start-up company Syntax transformed the lives of women allowing for more freedom, choice and the progression of equal rights. Today, 70 years after its creation, the contraceptive pill is taken by more than 3.1 million women in the UK. 

US Inventor Declarations and Assignments
news

US Inventor Declarations and Assignments

After a patent application has been filed, the inventor may be required to sign and submit various forms.  What happens if this is several years into the patent process, and the inventor can no longer be reached to sign these forms?  And what can you do now to prevent any complications from arising?

UKIPO ending temporary fee changes on 31 March 2021
news

UKIPO ending temporary fee changes on 31 March 2021

The UK Intellectual Property Office (UK IPO) temporarily reduced or removed certain official fees associated with patents, trade marks and registered designs because of the disruption caused by the Coronavirus pandemic. However, the temporary fee changes are set to end on 31 March 2021.

Insurance for IP Litigation Costs
news

Insurance for IP Litigation Costs

If you own any intellectual property (IP) rights, are you concerned about your exposure to litigation, and how you will finance any legal action?  One way to address this concern is by means of an insurance policy.

aipex logo aipex logo aipex logo we offer Covid-19 testing for our staff